e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
NRX Pharmaceuticals, Inc. - Common Stock
(NQ:
NRXP
)
2.375
-0.015 (-0.63%)
Streaming Delayed Price
Updated: 9:53 AM EST, Jan 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about NRX Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
FDA Denies Breakthrough Tag For NRx Pharma's COVID-19 Candidate
↗
November 24, 2021
Relief Therapeutics Holding SA's (OTC: RLFTF) collaborating partner NRx Pharmaceuticals Inc (NASDAQ: NRXP) has announced that the FDA has denied...
Via
Benzinga
20 Stocks Moving in Monday's Pre-Market Session
↗
November 22, 2021
Gainers Astra Space, Inc. (NASDAQ: ASTR) rose 39.6% to $13.30 in pre-market trading after declining around 3% on Friday. Astra Space recently reported a Q3 loss of $0.06 per...
Via
Benzinga
The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment
↗
November 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis...
Via
Benzinga
Earnings Scheduled For November 16, 2021
↗
November 16, 2021
Companies Reporting Before The Bell • Ozon Holdings (NASDAQ:OZON) is expected to report quarterly loss at $0.90 per share on revenue of $602.00 million. • Sea (...
Via
Benzinga
NRx Pharma's COVID-19 Candidate Receives FDA Review For Manufacturing Information
↗
November 11, 2021
NRx Pharmaceuticals Inc (NASDAQ: NRXP) has received the FDA's response to NRx's submission of updated manufacturing information for Zyesami (aviptadil)....
Via
Benzinga
Why NRX Pharmaceuticals Stock Is Jumping Today
↗
November 11, 2021
The company received good news from the FDA.
Via
The Motley Fool
64 Stocks Moving In Friday's Mid-Day Session
↗
November 05, 2021
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the...
Via
Benzinga
92 Biggest Movers From Friday
↗
November 08, 2021
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the...
Via
Benzinga
NRx Pharma Stock Nosedives As FDA Strikes Off Its COVID-19 Drug Hopeful
↗
November 05, 2021
The FDA has declined the emergency use authorization (EUA) for NRx Pharmaceuticals' (NASDAQ: NRXP) Zyesami (aviptadil). The Company is developing...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
November 05, 2021
Gainers Ontrak (NASDAQ:OTRK) shares rose 21.82% to $11.78 during Friday's pre-market session. The market value of their outstanding shares is at $225.5 million. As per...
Via
Benzinga
The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill
↗
November 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus NRx's COVID-19 Drug Fails to Get Authorization From FDA Due To...
Via
Benzinga
28 Stocks Moving in Friday's Pre-Market Session
↗
November 05, 2021
Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) rose 65.8% to $2.14 in pre-market trading after the company announced its ReBoot device has been granted designation as a Breakthrough...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
November 03, 2021
Good morning, trader! We're starting the day off right with a dive into the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
1 Small-Cap Stock With 10X Potential
↗
October 27, 2021
This company's coronavirus efforts could pay off big time.
Via
The Motley Fool
51 Biggest Movers From Friday
↗
October 18, 2021
Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 38.1% to close at $4.75 on Friday after declining around 15% on Thursday. The company recently announced it...
Via
Benzinga
Why NRx Pharmaceuticals Stock Is Tumbling Today
↗
October 15, 2021
The drugmaker is being sued by Relief Therapeutics.
Via
The Motley Fool
Topics
Lawsuit
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
October 15, 2021
Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares moved upwards by 29.96% to $7.72 during Friday's pre-market session. The company's market cap stands at $20.8...
Via
Benzinga
44 Biggest Movers From Yesterday
↗
October 15, 2021
Gainers Benessere Capital Acquisition Corp. (NASDAQ: BENER) shares jumped 66.5% to close at $0.4530 on Thursday. Grove, Inc. (NASDAQ: GRVI) gained 39.3% to close at $6.98 after...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 14, 2021
Gainers NRX Pharmaceuticals (NASDAQ:NRXP...
Via
Benzinga
Why NRx Pharmaceuticals Stock Is Jumping Again on Thursday
↗
October 14, 2021
New clinical trial results bode well for aviptadil in treating critically ill COVID-19 patients.
Via
The Motley Fool
Why NRX Pharmaceuticals Stock Is Surging Today
↗
October 14, 2021
NRX Pharmaceuticals Inc (NASDAQ: NRXP) is trading significantly higher Thursday after the company announced the Journal of Infectious Diseases and Treatment published trial...
Via
Benzinga
NRXP Stock: The Critical Covid-19 Trial Results That Have NRx Pharma Rocketing Higher
↗
October 14, 2021
NRX Pharmaceuticals (NRXP) stock is surging higher on Thursday thanks to recent results from a clinical trial of its Covid-19 treatment.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
October 14, 2021
Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock increased by 34.63% to $12.71 during Thursday's pre-market session. The company's market cap stands at $683.4...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 13, 2021
Gainers Statera BioPharma (NASDAQ:STAB) shares increased by 16.92% to $3.16 during Wednesday's regular session. The market value of their outstanding shares is at $87....
Via
Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
↗
October 13, 2021
Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares jumped 113% to $15.36 after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target...
Via
Benzinga
50 Biggest Movers From Yesterday
↗
October 14, 2021
Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating...
Via
Benzinga
20 Stocks Moving in Wednesday's Pre-Market Session
↗
October 13, 2021
Gainers Puxin Limited (NYSE: NEW) rose 52.1% to $0.6901 in pre-market trading after dipping 24% on Tuesday. Jasper Therapeutics, Inc. (NASDAQ: JSPR) rose 38% to $9.95 in pre-...
Via
Benzinga
45 Biggest Movers From Yesterday
↗
October 13, 2021
Gainers ESSTech Inc (NYSE: GWH) shares surged 128.4% to close at $23.80 onTuesday. ESS Inc, the Bill Gates-backed battery maker went public on the NewYork Stock Exchange on...
Via
Benzinga
NRXP Stock Is Soaring Today Thanks to This Big FDA Catalyst
↗
October 12, 2021
NRx Pharmaceuticals got some good news from the FDA and its shareholders are happy as NRXP stock enjoys a day of impressive gains.
Via
InvestorPlace
Why NRX Pharmaceuticals Shares Are Rising
↗
October 12, 2021
NRX Pharmaceuticals Inc (NASDAQ: NRXP) shares are trading higher by 54.1% at $10.45 after the company announced progress on the worldwide commercial-scale development of ZYESAMI....
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.